Life Science Logistics in a Life-Changing World, with Scott Ohanesian

As the COVID-19 crisis continues its dramatic impact on lives globally, in the life science space, patients who are being treated for non-COVID-19 illnesses still need to receive their treatments – even during a pandemic. Clinical trials must move forward. And medical supply chains have to be kept intact.

What’s more, while the virus rages, many companies around the world have quickly switched their focus to the development of a COVID-19 vaccine. The usually fast-paced world of life science logistics is now moving ever faster.

• So what goes into supporting logistics for clinical trials when confronted by so many pandemic-created obstacles?
• What solutions and services can help companies adhere to trial protocols, keep patients safe and ensure that their therapies are received on time?
• And what are the best logistics practices for overcoming an array of challenges – including government regulations, severely reduced airline schedules and dire economic situations.

Scott Ohanesian, Senior VP of QuickSTAT’s Commercial Operations in North America, works with pharmaceutical and biotech companies on designing comprehensive clinical trial logistics plans. In his years of work, Scott has created customized supply chain solutions – from pre-clinical to clinical to commercialization – that meet client objectives, maintain product integrity and ensure patient safety.

To learn more about Quick’s global logistics solutions, go to quick.aero/podcasts.